American Oncology Network, Inc.
AONC
$4.80
$0.000.00%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.58B | 1.45B | 1.33B | 1.27B | 1.24B |
| Total Other Revenue | 14.01M | 13.32M | 14.34M | 13.47M | 12.30M |
| Total Revenue | 1.59B | 1.46B | 1.34B | 1.28B | 1.26B |
| Cost of Revenue | 1.51B | 1.38B | 1.27B | 1.19B | 1.15B |
| Gross Profit | 86.65M | 75.53M | 69.71M | 85.51M | 103.66M |
| SG&A Expenses | 130.35M | 120.81M | 107.99M | 103.43M | 95.93M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.64B | 1.50B | 1.38B | 1.30B | 1.25B |
| Operating Income | -43.70M | -45.28M | -38.28M | -17.92M | 7.73M |
| Income Before Tax | -49.08M | -61.20M | -56.27M | -35.69M | -13.40M |
| Income Tax Expenses | 2.64M | 2.95M | 3.28M | 384.00K | 315.00K |
| Earnings from Continuing Operations | -51.72 | -64.16 | -59.55 | -36.07 | -13.72 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 42.68M | 54.39M | 47.65M | 30.53M | 11.92M |
| Net Income | -9.04M | -9.76M | -11.90M | -5.54M | -1.79M |
| EBIT | -43.70M | -45.28M | -38.28M | -17.92M | 7.73M |
| EBITDA | -34.16M | -36.25M | -29.54M | -9.47M | 15.50M |
| EPS Basic | -2.03 | -2.45 | -2.46 | -1.24 | -0.49 |
| Normalized Basic EPS | 1.15 | 2.58 | 1.88 | 1.41 | 1.08 |
| EPS Diluted | -2.27 | -2.69 | -2.46 | -1.24 | -0.50 |
| Normalized Diluted EPS | 0.88 | 2.32 | 1.88 | 1.41 | 1.08 |
| Average Basic Shares Outstanding | 39.07M | 32.42M | 34.26M | 26.73M | 19.83M |
| Average Diluted Shares Outstanding | 64.78M | 58.13M | 34.26M | 26.73M | 19.83M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -104.88% | -110.50% | -159.38% | -342.13% | -529.07% |
